Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06097078 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer

Study acronym: ESPY
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 8 months later Jan 31, 2026 → Oct 2026
See other at-risk trials from Aesculap AG

Record History

  1. Primary completion pushed from Jan 31, 2026 to Oct 2026 Completion pushed from Jul 2026 to Dec 2026 · Eligibility criteria expanded, about 15 words · Secondary endpoints: details revised at 4 of 10 entries Show 3 more changesShow less
    • Completion pushed from Jul 2026 to Dec 2026
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 4 of 10 entries
  2. Trial status: Recruiting to Active, Not Recruiting Primary completion date changed from estimate of Apr 2026 to Jan 31, 2026 · Completion date: Apr 2026 to Jul 2026 · Site details revisedv9 Show 3 more changesShow less
    • Primary completion date changed from estimate of Apr 2026 to Jan 31, 2026
    • Completion date: Apr 2026 to Jul 2026
    • Site details revised
  3. Primary and study completion dates: Oct 2025 to Apr 2026v8
  4. Re-verified, no change to tracked fieldsv7
  5. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Jun 2025 to Oct 2025 · Start date changed from estimate of Oct 2024 to Oct 7, 2024 · Site details revisedv6 Show 3 more changesShow less
    • Primary completion date: Jun 2025 to Oct 2025
    • Start date changed from estimate of Oct 2024 to Oct 7, 2024
    • Site details revised
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Aug 2024 to Oct 2024v5
  2. Start date: Jun 2024 to Aug 2024v4
  3. Start date: Mar 2024 to Jun 2024 Primary completion date: Mar 2025 to Jun 2025 · Completion date: Jul 2025 to Oct 2025v3 Show 2 more changesShow less
    • Primary completion date: Mar 2025 to Jun 2025
    • Completion date: Jul 2025 to Oct 2025
  4. Start date: Dec 2023 to Mar 2024 Primary completion date: Dec 2024 to Mar 2025 · Completion date: Apr 2025 to Jul 2025v2 Show 2 more changesShow less
    • Primary completion date: Dec 2024 to Mar 2025
    • Completion date: Apr 2025 to Jul 2025
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aesculap AG
32 trials monitored
See 6 trials at risk
Esophageal Cancer
1,012 trials monitored
See 53 trials at risk
A prospective, multi-centre, exploratory and observational one-arm study to evaluate preventive Endoluminal Vacuum Therapy(pEVT) to prevent anastomotic leakage after esophagectomy due to esophageal cancer. The main objective is to evaluate the potential protective effect of prophylactic preemptive endoluminal vacuum therapy on esophageal-gastric anastomosis dehiscence after esophagectomy.
Trial Details
NCT Number NCT06097078
Lead Sponsor Aesculap AG
Collaborators: B.Braun Surgical SA
Conditions Esophageal Cancer, Esophagus Cancer, Anastomotic Leak
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov